Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marla Karine Amarante is active.

Publication


Featured researches published by Marla Karine Amarante.


Journal of Cancer Research and Clinical Oncology | 2009

The possible involvement of virus in breast cancer.

Marla Karine Amarante; Maria Angelica Ehara Watanabe

It is well known that the etiology of human breast cancer is significantly affected by environmental factors. Virus-associated cancer refers to a cancer where viral infection results in the malignant transformation of the host’s infected cells. Human papillomaviruses (HPV), mouse mammary tumor virus (MMTV) and Epstein–Barr (EBV) virus are prime candidate viruses as agents of human breast cancer. The precise role that viruses play in tumorigenesis is not clear, but it seems that they are responsible for causing only one in a series of steps required for cancer development. The idea that a virus could cause breast cancer has been investigated for quite some time, even though breast cancer could be a hereditary disease; however, hereditary breast cancer is estimated to account for a small percentage of all breast cancer cases. Based on current research, this review present at moment, substantial, but not conclusive, evidence that HPV, EBV and MMTV may be involved in breast cancer.


Journal of Pharmacy and Pharmacology | 2011

Cytotoxic constituents of propolis inducing anticancer effects: a review.

Maria Angelica Ehara Watanabe; Marla Karine Amarante; Bruno José Conti; José Maurício Sforcin

Objectives  Propolis is a honeybee product used extensively in traditional medicine for its antioxidant, anti‐inflammatory, immunomodulatory and anticancer effects. Propolis exhibits a broad spectrum of biological activities because it is a complex mixture of natural substances. In this review, the antitumour effects of propolis extracts and its constituents (e.g. flavonoids, terpenes and caffeic acid phenethyl ester) are discussed.


Cancer and Metastasis Reviews | 2010

Regulatory T cells and breast cancer: implications for immunopathogenesis

Maria Angelica Ehara Watanabe; Julie Massayo Maeda Oda; Marla Karine Amarante; Júlio C. Voltarelli

Current understanding of the role of several cancer risk factors is more comprehensive, as reported for a number of sites, including the brain, colon, breasts, and ovaries. Despite such advances, the incidence of breast cancer continues to increase worldwide. Signals from the microenviroment have a profound influence on the maintenance or progression cancers. Although T cells present the most important immunological response in tumor growth in the early stages of cancer, they become suppressive CD4+ and CD8+ regulatory T cells (Tregs) after chronic stimulation and interactions with tumor cells, thus promoting rather than inhibiting cancer development and progression. Tregs have an important marker protein which is FoxP3, though it does not necessarily confer a Treg phenotype when expressed in CD4+ T lymphocytes. High Treg levels have been reported in peripheral blood, lymph nodes, and tumor specimens from patients with different types of cancer. The precise mechanisms by which Tregs suppress immune cell functions remain unclear, and there are reports of both direct inhibition through cell–cell contact and indirect inhibition through the secretion of anti-inflammatory mediators such as interleukin. In this review, we present the molecular and immunological aspects of Treg cells in the metastasis of breast cancer.


Journal of Clinical Laboratory Analysis | 2008

RNA from Borna disease virus in patients with schizophrenia, schizoaffective patients, and in their biological relatives

Sandra Odebrechet Vargas Nunes; Eiko Nakagawa Itano; Marla Karine Amarante; Edna Maria Vissoci Reiche; Helen Cristina Miranda; Carlos Eduardo Coral de Oliveira; Tiemi Matsuo; Heber Odebrechet Vargas; Maria Angelica Ehara Watanabe

Numerous interactions of the immune system with the central nervous system have been described recently. Mood and psychotic disorders, such as severe depression and schizophrenia, are both heterogeneous disorders regarding clinical symptomatology, the acuity of symptoms, the clinical course, the treatment response, and probably also the etiology. Detection of p24 RNA from Borna disease virus (BDV) by the reverse transcriptase polymerase chain reaction in patients with schizophrenia, schizoaffective disorder, and in their biological relatives was evaluated. The subjects were 27 schizophrenic and schizoaffective patients, 27 healthy controls, 20 relatives without psychiatric disease, and 24 relatives with mood disorder, who attended the Psychiatric Ambulatory of Londrina State University, Paraná, Brazil. The subjects were interviewed by structured diagnostic criteria categorized according to the Diagnostic and Statistical Manual of Mental Disorders‐IV, axis I, (SCID‐IV). The mean duration of illness in schizophrenic and schizoaffective patients was 15.341±1.494 years and the median age at onset was 22.4±7.371 years. There were no significant differences in gender (P=0.297), age (P=0.99), albumin (P=0.26), and body mass index (kg/m2) (p=0.28), among patients, controls, and relatives. Patients and biological relatives had significantly higher positive p24 RNA BDV detection than controls (P=0.04); however, the clinical significance of BDV remains to be clarified. J. Clin. Lab. Anal. 22:314–320, 2008.


International Reviews of Immunology | 2010

Toll-like receptor 3: involvement with exogenous and endogenous RNA.

Marla Karine Amarante; Maria Angelica Ehara Watanabe

The recognition of pathogens is assigned to an evolutionarily conserved family of receptors, the Toll-like receptors (TLRs). The investigation of RNA-based immunology has been reinvigorated with the observation that TLR3s interact with RNA (dsRNA of viral origin, poly (I:C) and endogenous RNA). Many RNAs, therefore, join the list of endogenous ligands for TLRs. The further finding that nucleoside modification alters RNA-mediated TLR signaling presents a mechanism for the long-observed differences in immunogenicity. The involvement of RNA modification in the pathogenesis of diseases, and its implications in the therapeutics, are still being studied, and will have important implications in the future.


Journal of Genetics | 2011

Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour

Maria Angelica Ehara Watanabe; Sandra Odebrechet Vargas Nunes; Marla Karine Amarante; Roberta Losi Guembarovski; Julie Massayo Maeda Oda; Kalil William Alves de Lima; Maria Helena Pelegrinelli Fungaro

Data suggest that the serotonin (5-hydroxytryptamine, 5-HT) system is implicated in the pathogenesis of multiple neuropsychiatric disorders and may also be involved in smoking behaviour since nicotine increases brain serotonin secretion. It is known that smoking behaviour is influenced by both genetic and environmental factors. The present review examines the role of the serotonin transporter gene (5-HTT) in smoking behaviour and investigating studies that showed association of 5-HTT gene with smoking. This study discusses a polymorphism which has been investigated by many researchers, as the bi-allelic insertion/deletion polymorphism in the 5′- flanking promoter region (5-HTTLPR). This gene has received considerable attention in attempts to understand the molecular determinants of smoking. Therefore, in the present study, the relationship between genetic polymorphism of serotonin transporter in smoking behaviour is reviewed considering the interactive effect of genetic factors.


Analytical Cellular Pathology | 2015

Immunohistochemical expression of CXCR4 on breast cancer and its clinical significance.

Marina Okuyama Kishima; Carlos Eduardo Coral de Oliveira; Bruna Karina Banin-Hirata; Roberta Losi-Guembarovski; Karen Brajão de Oliveira; Marla Karine Amarante; Maria Angelica Ehara Watanabe

Many tumor cells express chemokines and chemokine receptors, and, for this reason, these molecules can affect the tumor progression. It is known that breast cancer is a complex and heterogeneous neoplasia comprising distinct diseases, histological characteristics, and clinical outcomes. The most studied role for CXCL12 chemokine and its receptor CXCR4 in breast cancer pathogenesis is the metastasis event, although several reports have demonstrated its involvement in other processes, such as angiogenesis and tumor growth. It has been found that CXCR4 is required for breast cancer cell migration to other sites such as lung, bone, and lymph nodes, which express high levels of CXCL12 chemokine. Therefore, CXCR4 is being considered a prognostic marker in breast cancer. Within this context, this review summarizes established studies involving expression of CXCR4 on breast cancer, focusing on its clinical significance.


Journal of Pharmacy and Pharmacology | 2012

The effect of propolis on CCL5 and IFN-γ expression by peripheral blood mononuclear cells from leishmaniasis patients

Marla Karine Amarante; Maria Angelica Ehara Watanabe; Ivete Conchon-Costa; Leandra Lopes Fiori; Julie Massayo Maeda Oda; Michelle Cristiane Búfalo; José Maurício Sforcin

Objectives  Mucocutaneous leishmaniasis is associated with a strong Th1 immune response to Leishmania, which modulates chemokines and their receptors expression, affecting their migratory capacity. There are no antileishmanial vaccines available and chemotherapy still relies on the potentially toxic pentavalent antimonials. Propolis is a bee product with immunomodulatory and antiparasite activities, and researchers have been attracted to its potential for the development of new drugs. This work investigated the effects of propolis on CCL5 and IFN‐γ expression by peripheral blood mononuclear cells (PBMC) in order to evaluate a possible immunomodulatory action of propolis in patients with leishmaniasis compared to healthy control subjects.


Journal of Clinical Laboratory Analysis | 2008

Association study of CCR5 delta 32 polymorphism among the HLA-DRB1 Caucasian population in Northern Paraná, Brazil.

Sandra Márcia Muxel; Sueli Donizete Borelli; Marla Karine Amarante; Júlio C. Voltarelli; Mateus Nóbrega Aoki; Carlos Eduardo Coral de Oliveira; Maria Angelica Ehara Watanabe

Chemokines are important determinants of early inflammatory response. The CC chemokine receptor 5 (CCR5) delta 32 variant results in a nonfunctional form of the chemokine receptor and has been implicated in a variety of immune‐mediated diseases. In the present study, polymerase chain reaction (PCR) for genomic deoxyribonucleic acid (DNA) samples, using specific CCR5 oligonucleotide primers surrounding the breakpoint deletion, detected a 225‐basepair (bp) product from the normal CCR5 allele and a 193‐bp product from the 32 bp deletion allele. Human leukocyte antigen (HLA) class II (DRB1) typing was performed by PCR‐sequence‐specific primer (PCR‐SSP). The aim of this study was to evaluate the association of HLA‐DRB1 and CCR5 genetic polymorphisms. To evaluate the frequency distributions of CCR5 delta 32 polymorphisms in a Brazilian population and their association with allelic distribution of HLA genes, DRB1; a total of 120 Caucasian individuals from northern Paraná, Brazil, were tested. The CCR5/CCR5 genotype was found in 108 individuals (90%) and only one carried the CCR5 delta 32 allele homozygous genotype (0.0238), while 12 (10%) carried the CCR5 delta 32 allele heterozygous genotype. The observed frequency for the CCR5 delta 32 allele was 0.05 in the population studied. The results revealed a CCR5 delta 32 allele occurrence with HLA‐DRB1*01 and DRB1*04 (P<0.05). It is possible that HLA‐DRB1*01 and DRB1*04 alleles could be associated with the delta 32‐bp deletion of CCR5. J. Clin. Lab. Anal. 22:229–233, 2008.


Microbial Pathogenesis | 2009

Detection of TT virus in HIV-1 exposed but uninfected individuals and in HIV-1 infected patients and its influence on CD4+ lymphocytes and viral load.

Thiago Franco Nasser; Karen Brajão de Oliveira; Edna Maria Vissoci Reiche; Marla Karine Amarante; Maria Helena Pelegrinelli Fungaro; Maria Angelica Ehara Watanabe

The TT virus (TTV) was detected for the first time in the serum of a patient with post-transfusion hepatitis of unknown origin. TTV was subsequently, also found in the serum of blood donors with no history of blood transfusion. In the present study, the percentage of TTV carriers among HIV-infected and noninfected patients was determined. The study was conducted to evaluate CD4 count and HIV viral load in 100 asymptomatic patients infected with HIV-1, 100 symptomatic patients with AIDS, 100 HIV-1 exposed but uninfected individuals and 100 normal healthy blood donors. In this work, the presence of TTV was investigated by nested-PCR. TTV was detected in 6% of normal donors, 12.5% of HIV-infected individuals and 21% of exposed individuals. The presence of TTV was statistically significant in the HIV-exposed individuals (21/100) compared with blood donors (6/100). Odds ratio=4.16 (95%CI 1.60-10.83). No inter-group relations were found for CD4 and CD8 counts or HIV viral load. In the symptomatic group, patients with TTV presented minor viral load. This work demonstrated that TTV was detected in HIV-exposed individuals and no relation was verified for CD4, CD8 and viral load in the asymptomatic and symptomatic HIV patients.

Collaboration


Dive into the Marla Karine Amarante's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Julie Massayo Maeda Oda

Universidade Estadual de Londrina

View shared research outputs
Top Co-Authors

Avatar

Mateus Nóbrega Aoki

Universidade Estadual de Londrina

View shared research outputs
Top Co-Authors

Avatar

Karen Brajão de Oliveira

Universidade Estadual de Londrina

View shared research outputs
Top Co-Authors

Avatar

Roberta Losi Guembarovski

Universidade Estadual de Londrina

View shared research outputs
Top Co-Authors

Avatar

Thiago Cezar Fujita

Universidade Estadual de Londrina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aparecida de Lourdes Perim

Universidade Estadual de Londrina

View shared research outputs
Researchain Logo
Decentralizing Knowledge